Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Shares Outstanding (Diluted Average) (2021 - 2024)

Historic Shares Outstanding (Diluted Average) for Lemaitre Vascular (LMAT) over the last 10 years, with Q4 2024 value amounting to $22.8 million.

  • Lemaitre Vascular's Shares Outstanding (Diluted Average) rose 158.77% to $22.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $22.8 million, marking a year-over-year increase of 158.77%. This contributed to the annual value of $22.8 million for FY2024, which is 158.77% up from last year.
  • According to the latest figures from Q4 2024, Lemaitre Vascular's Shares Outstanding (Diluted Average) is $22.8 million, which was up 158.77% from $22.4 million recorded in Q4 2023.
  • In the past 5 years, Lemaitre Vascular's Shares Outstanding (Diluted Average) registered a high of $22.8 million during Q4 2024, and its lowest value of $21.5 million during Q4 2021.
  • In the last 4 years, Lemaitre Vascular's Shares Outstanding (Diluted Average) had a median value of $22.3 million in 2022 and averaged $22.2 million.
  • Per our database at Business Quant, Lemaitre Vascular's Shares Outstanding (Diluted Average) surged by 324.1% in 2022 and then surged by 113.66% in 2023.
  • Quarter analysis of 4 years shows Lemaitre Vascular's Shares Outstanding (Diluted Average) stood at $21.5 million in 2021, then grew by 3.24% to $22.2 million in 2022, then rose by 1.14% to $22.4 million in 2023, then grew by 1.59% to $22.8 million in 2024.
  • Its last three reported values are $22.8 million in Q4 2024, $22.4 million for Q4 2023, and $22.2 million during Q4 2022.